Biphenotypic, bilineal, ambiguous or mixed lineage: Strange leukemias!

Haematologica

Volumn 94, Issue 7, 2009, Pages 891-893

  Béné, Marie C ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE BIPHENOTYPIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; DISEASE CLASSIFICATION; EDITORIAL; LEUKEMIA;

ACUTE DISEASE; CELL DIFFERENTIATION; CELL LINEAGE; CHROMOSOMES; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA; LEUKEMIA, BIPHENOTYPIC, ACUTE; MEDICAL ONCOLOGY; PHENOTYPE;

EID: 67650744340     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2009.007799     Document Type: Editorial

References (20)

1. Xu X-Q, Wang J-M, Lu S-Q, Chen Li, Yang J-M, Zhang J-P, et al. Clinical and biological characteristics of adult biphenotypic acute leukemia in comparison with that of acute myeloid leukemia and acute lymphoblastic leukemia: a case series of a Chinese population. Haematologica 2009;94:919-927.
2. McGraw TP, Folds JD, Bollum FJ, Stass SA. Terminal deoxynucleotidyl transferase-positive acute myeloblastic leukemia. Am J Hematol 1981;10:251-8.
3. Coleman MS, Greenwood MF, Hutton JJ, Bollum FJ, Lampkin B, Holland P. Serial observations on terminal deoxynucleotidyl transferase activity and lymphoblast surface markers in acute lymphoblastic leukemia. Cancer Res 1976;36:120-7.
4. Bollum FJ. Terminal deoxynucleotidyl transferase as a hematopoietic cell marker. Blood 1979;54:1203-15.
5. Scamurra DO, Davey FR, Nelson DA, Kurec AS, Goldberg J. Acute leukemia presenting with myeloid and lymphoid cell markers. Ann Clin Lab Sci 198;13:496-502.
6. Catovsky D, Matutes E, Buccheri V, Shetty V, Hanslip J, Yoshida N, Morilla R. A classification of acute leukaemia for the 1990s. Ann Hematol 1991;62:16-21.
7. Béné MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, van't Veer MB. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 1995;9:1783-6.
8. Maynadié M, Campos L, Moskovtchenko P, Sabido O, Aho S, Lenormand B, et al. Heterogenous expression of CD15 in acute lymphoblastic leukemia: a study of ten anti-CD15 monoclonal antibodies in 158 patients. Leuk Lymphoma 1997;25:135-43.
9. Albano F, Mestice A, Pannunzio A, Lanza F, Martino B, Pastore D, et al. The biological characteristics of CD34+ CD2+ adult acute promyelocytic leukemia and the CD34 CD2 hypergranular (M3) and microgranular (M3v) phenotypes. Haematologica 2006;91:311-6.
10. Béné MC, Bernier M, Casasnovas RO, Castoldi G, Knapp W, Lanza F, et al. The reliability and specificity of c-kit for the diagnosis of acute myeloid leukemias and undifferentiated leukemias. The European Group for the Immunological Classification of Leukemias (EGIL). Blood 1998;92:596-9.
11. Wood BL, Arroz M, Barnett D, DiGiuseppe J, Greig B, Kussick SJ, et al. 2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia. Cytometry B Clin Cytom 2007;72 (Suppl 1):S14-22.
12. Lacombe F, Arnoulet C, Durrieu F, Feuillard J, Fossat C, Husson B, et al. Flow cytometry atlas [monograph on the Internet]. Mannheim: European Leukemia Net, 2009. Available from: http://www.leukemia-net.org/content/diagnostics/.
13. Matutes E, Morilla R, Farahat N, Carbonell F, Swansbury J, Dyer M, Catovsky D. Definition of acute biphenotypic leukemia. Haematologica 1997;82:64-6.
14. Borowitz MJ, Béné M-C, Harris NL, Porwit A, Matutes E. Acute leukaemias of ambiguous lineage. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: WHO Press; 2008. p. 150-5.
15. Casasnovas RO, Slimane FK, Garand R, Faure GC, Campos L, Deneys V, et al. Immunological classification of acute myeloblastic leukemias: relevance to patient outcome. Leukemia 2003;17:515-27.
16. Feuillard J, Jacob MC, Valensi F, Maynadié M, Gressin R, Chaperot L, et al. Clinical and biologic features of CD4(+)CD56(+) malignancies. Blood 2002;99:1556-63.
17. Sirvent A, Benistant C, Roche S. Cytoplasmic signalling by the c-Abl tyrosine kinase in normal and cancer cells. Biol Cell 2008;100:617-31.
18. Slany RK. The molecular biology of mixed lineage leukemia. Haematologica 2009;94:984-993.
19. Ziemin-van der Poel S, McCabe NR, Gill HJ, Espinosa R 3rd, Patel Y, Harden A, et al. Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias. Proc Natl Acad Sci USA 1991;88:10735-9.
20. De Braekeleer M, Morel F, Le Bris MJ, Herry A, Douet-Guilbert N. The MLL gene and translocations involving chromosomal band 11q23 in acute leukemia. Anticancer Res 2005;25:1931-44.